This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
Our admissions team will work with you to explore the right payment options based on your needs, ensuring you get the best possible treatment.
Saint Luke's Penn Foundation treats adolescents, adults, veterans and families facing mental health and substance use challenges. It provides a full continuum of care, from inpatient to outpatient services, and is part of Saint Luke’s integrated health network in eastern Pennsylvania. The center’s faith-rooted comprehensive approach to treating complex co-occurring disorders, ensures clients receive coordinated and holistic care.
Their holistic approach to treatment focuses on each individual, combining different methods such as individual, group, faith-based and family counselling, medication management, cognitive behavioral therapy ( CBT), and creative therapies like art and drumming. This combination of therapies helps clients develop coping skills, address underlying issues, and build a strong foundation for lasting recovery.
Penn Foundation’s Assertive Community Treatment (ACT) provides intensive, person-centered care for patients 18 and older, with serious mental illness. A mobile, multidisciplinary team of specialists in psychiatry, nursing, and social work delivers highly individualized treatment and rehabilitation in community settings. By minimizing symptoms and the need for hospitalization, the program promotes individuals to be highly functional, independent to have an enhanced quality of life.

This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
CARF stands for the Commission on Accreditation of Rehabilitation Facilities. It's an independent, non-profit organization that provides accreditation services for a variety of healthcare services. To be accredited means that the program meets their standards for quality, effectiveness, and person-centered care.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.

Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.